BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18025475)

  • 1. Tumor immune escape by the loss of homeostatic chemokine expression.
    Pivarcsi A; Müller A; Hippe A; Rieker J; van Lierop A; Steinhoff M; Seeliger S; Kubitza R; Pippirs U; Meller S; Gerber PA; Liersch R; Buenemann E; Sonkoly E; Wiesner U; Hoffmann TK; Schneider L; Piekorz R; Enderlein E; Reifenberger J; Rohr UP; Haas R; Boukamp P; Haase I; Nürnberg B; Ruzicka T; Zlotnik A; Homey B
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):19055-60. PubMed ID: 18025475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CBP/p300 antagonises EGFR-Ras-Erk signalling and suppresses increased Ras-Erk signalling-induced tumour formation in mice.
    Ichise T; Yoshida N; Ichise H
    J Pathol; 2019 Sep; 249(1):39-51. PubMed ID: 30953353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma.
    Kai H; Kadono T; Kakinuma T; Tomita M; Ohmatsu H; Asano Y; Tada Y; Sugaya M; Sato S
    Pathol Res Pract; 2011 Jan; 207(1):43-8. PubMed ID: 21144674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukotriene B(4) enhances tumour necrosis factor-alpha-induced CCL27 production in human keratinocytes.
    Kanda N; Watanabe S
    Clin Exp Allergy; 2007 Jul; 37(7):1074-82. PubMed ID: 17581202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis.
    Cataisson C; Michalowski AM; Shibuya K; Ryscavage A; Klosterman M; Wright L; Dubois W; Liu F; Zhuang A; Rodrigues KB; Hoover S; Dwyer J; Simpson MR; Merlino G; Yuspa SH
    Sci Signal; 2016 Jun; 9(433):ra62. PubMed ID: 27330189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Tpl2 activates compensatory signaling and resistance to EGFR/MET dual inhibition in v-RAS transduced keratinocytes.
    Kelley MB; Geddes TJ; Ochiai M; Lampl NM; Kothmann WW; Fierstein SR; Kent V; DeCicco-Skinner K
    PLoS One; 2022; 17(3):e0266017. PubMed ID: 35325006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL27 is downregulated by interferon gamma via epidermal growth factor receptor in normal human epidermal keratinocytes.
    Karakawa M; Komine M; Hanakawa Y; Tsuda H; Sayama K; Tamaki K; Ohtsuki M
    J Cell Physiol; 2014 Dec; 229(12):1935-45. PubMed ID: 24710735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient receptor potential vanilloid 4 (TRPV4) is downregulated in keratinocytes in human non-melanoma skin cancer.
    Fusi C; Materazzi S; Minocci D; Maio V; Oranges T; Massi D; Nassini R
    J Invest Dermatol; 2014 Sep; 134(9):2408-2417. PubMed ID: 24643128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (2S)-2′-methoxykurarinone from Sophora flavescens suppresses cutaneous T cell-attracting chemokine/CCL27 expression induced by interleukin-ß/tumor necrosis factor-α via heme oxygenase-1 in human keratinocytes.
    Jeong SI; Lee YE; Jang SI
    J Med Food; 2010 Oct; 13(5):1116-24. PubMed ID: 20883179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology of basal and squamous cell carcinomas.
    Emmert S; Schön MP; Haenssle HA
    Adv Exp Med Biol; 2014; 810():234-52. PubMed ID: 25207369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa).
    Barnes CJ; Bagheri-Yarmand R; Mandal M; Yang Z; Clayman GL; Hong WK; Kumar R
    Mol Cancer Ther; 2003 Apr; 2(4):345-51. PubMed ID: 12700278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAPK/ERK-dependent translation factor hyperactivation and dysregulated laminin γ2 expression in oral dysplasia and squamous cell carcinoma.
    Degen M; Natarajan E; Barron P; Widlund HR; Rheinwald JG
    Am J Pathol; 2012 Jun; 180(6):2462-78. PubMed ID: 22546478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C delta.
    Denning MF; Dlugosz AA; Threadgill DW; Magnuson T; Yuspa SH
    J Biol Chem; 1996 Mar; 271(10):5325-31. PubMed ID: 8621384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
    Uribe P; Gonzalez S
    Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes.
    Kanda N; Koike S; Watanabe S
    J Allergy Clin Immunol; 2005 Nov; 116(5):1144-50. PubMed ID: 16275389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the transcriptional consequences of epidermal growth factor receptor ablation in Ras-initiated squamous cancer.
    Wright LN; Ryscavage A; Merlino G; Yuspa SH
    Clin Cancer Res; 2012 Jan; 18(1):170-83. PubMed ID: 22068661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD95 (Fas) in sun-exposed human skin and cutaneous carcinomas.
    Filipowicz E; Adegboyega P; Sanchez RL; Gatalica Z
    Cancer; 2002 Feb; 94(3):814-9. PubMed ID: 11857317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL27 expression is regulated by both p38 MAPK and IKKβ signalling pathways.
    Riis JL; Johansen C; Vestergaard C; Otkjaer K; Kragballe K; Iversen L
    Cytokine; 2011 Dec; 56(3):699-707. PubMed ID: 21993219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional roles of Akt signaling in mouse skin tumorigenesis.
    Segrelles C; Ruiz S; Perez P; Murga C; Santos M; Budunova IV; Martínez J; Larcher F; Slaga TJ; Gutkind JS; Jorcano JL; Paramio JM
    Oncogene; 2002 Jan; 21(1):53-64. PubMed ID: 11791176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.